MLN0128, an ATP-competitive mTOR kinase inhibitor with potent in vitro and in vivo antitumor activity, as potential therapy for bone and soft-tissue sarcoma (Q35096201)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
MLN0128, an ATP-competitive mTOR kinase inhibitor with potent in vitro and in vivo antitumor activity, as potential therapy for bone and soft-tissue sarcoma
scientific article

    Statements

    MLN0128, an ATP-competitive mTOR kinase inhibitor with potent in vitro and in vivo antitumor activity, as potential therapy for bone and soft-tissue sarcoma (English)
    0 references
    Emily K Slotkin
    Parag P Patwardhan
    Shyamprasad D Vasudeva
    William D Tap
    Gary K Schwartz
    17 December 2014

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit